Dr David Taylor, DO | |
673d Medical Group, 5955 Zeamer Avenue, Jber, AK 99506 | |
(907) 580-5804 | |
Not Available |
Full Name | Dr David Taylor |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 673d Medical Group, Jber, Alaska |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497011142 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 1163 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr David Taylor, DO 673d Medical Group, 5955 Zeamer Avenue, Jber, AK 99506 Ph: (907) 580-5804 | Dr David Taylor, DO 673d Medical Group, 5955 Zeamer Avenue, Jber, AK 99506 Ph: (907) 580-5804 |
News Archive
Simbionix USA Corp, an international company using leading edge simulation to advance clinical performance, announces the world-wide release of a breakthrough training simulation of the laparoscopic colorectal procedure.
W. L. Gore & Associates (Gore) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market a 45 mm diameter version of the GOREĀ® TAGĀ® Thoracic Endoprosthesis for treatment of aneurysms of the descending thoracic aorta. The larger diameter device allows treatment of TAAs with proximal and distal neck diameters ranging from 37 - 42 mm and is now available for commercial use in the U.S.
The popular DASH diet, established by the National Institutes of Health as a way to lower blood pressure and cholesterol levels, may have health benefits that go beyond its stated purpose of lowering people's risk of heart disease, according to research published in the November issue of the Journal of the American Dietetic Association.
In the event of an infection, the immune system releases messenger substances. These molecules can either activate immune cells to defeat invading pathogens, or inhibit them to prevent an excessive immune reaction. For this, the immune system has to decide very quickly what mixture of activating and inhibiting messenger molecules leads to a successful defence.
Senescent cells prevent tissue recovery following spinal cord injury, and a new drug targeting these cells could therefore improve functional recovery capacity.
› Verified 4 days ago
Dr. Kleve Woods Granger, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-5804 |